Market Report, "Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H1 2017", Published
Muscarinic Acetylcholine Receptor M4 (CHRM4) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are developed by Companies. The latest report Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H1 2017, outlays comprehensive information on the Muscarinic Acetylcholine Receptor M4 (CHRM4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
View full press release